Allspring Global Investments’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-5,637
Closed -$369K – 1968
2026
Q1
$369K Buy
5,637
+575
+11% +$52.4K ﹤0.01% 1476
2025
Q4
$670K Buy
5,062
+440
+10% +$60.4K ﹤0.01% 1296
2025
Q3
$524K Sell
4,622
-1,369
-23% -$149K ﹤0.01% 1338
2025
Q2
$541K Sell
5,991
-184,306
-97% -$14.5M ﹤0.01% 1319
2025
Q1
$16.1M Buy
190,297
+100,146
+111% +$8.69M 0.03% 584
2024
Q4
$7.18M Buy
90,151
+89,974
+50,833% +$6.28M 0.01% 853
2024
Q3
$7.51K Buy
+177
New +$5.98K ﹤0.01% 2128

Other funds holding WGS

Allspring Global Investments's WGS Position: Q2 2026 in Review

Allspring Global Investments sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 5,637 shares — an estimated $369K sold.

Allspring Global Investments first reported a position in WGS in Q3 2024 and held it in 7 quarters. The position peaked at $16.1M in Q1 2025. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Allspring Global Investments reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Allspring Global Investments sold 5,637 GeneDx Holdings shares in Q2 2026, an estimated $369K.
  • Allspring Global Investments first reported a position in GeneDx Holdings in Q3 2024 and held it in 7 quarters.
  • Allspring Global Investments's GeneDx Holdings position peaked at $16.1M in Q1 2025.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.